ArticleJCI insight2021

Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer.

W Nathaniel Brennen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.